Fresenius Medical Care AG & Co KGaA ADR buy Societe Generale
Start price
17.11.23
/
50%
€17.70
Target price
17.11.24
-
Performance (%)
7.25%
Price
25.07.24
€18.40
Summary
This prediction is currently active. With a performance of 7.25%, the BUY prediction by Societe_Generale for Fresenius Medical Care AG & Co KGaA ADR is trending in the right direction. A total of €0.58 was paid as dividends for this prediction. This prediction currently runs until 17.11.24. The prediction end date can be changed by Societe_Generale at any time. Societe_Generale has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Fresenius Medical Care AG & Co KGaA ADR | -2.174% | -2.174% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by Societe_Generale for this prediction
In the thread Fresenius Medical Care AG & Co KGaA ADR diskutieren
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) was upgraded by analysts at Societe Generale from a "hold" rating to a "buy" rating.
Ratings data for FMS provided by MarketBeat